삼성서울병원

Ko En
의료진 검색
찾으실 의료진명을 입력하여 검색해주세요.

내분비대사내과 김선욱 교수

진료분야
갑상선질환
진료일정 05 月
날짜
수
01
목
02
금
03
토
04
일
05
월
06
화
07
수
08
목
09
금
10
토
11
일
12
월
13
화
14
수
15
목
16
금
17
토
18
일
19
월
20
화
21
수
22
목
23
금
24
토
25
일
26
월
27
화
28
수
29
목
30
금
31
오전
오후
진료일정 06 月
날짜
토
01
일
02
월
03
화
04
수
05
목
06
금
07
토
08
일
09
월
10
화
11
수
12
목
13
금
14
토
15
일
16
월
17
화
18
수
19
목
20
금
21
토
22
일
23
월
24
화
25
수
26
목
27
금
28
토
29
일
30
오전
오후
본원외래 본원클리닉 본원육아상담 암병원외래 암병원클리닉 암병원육아상담

학력

학력
2005.08 서울대학교 의과대학원 의학과 (박사)
1997.02 서울대학교 의과대학원 의학과 (석사)
1992.02 서울대학교 의과대학 의학과 졸업 (의학사)

경력

경력
2023.04 ~현재 삼성서울병원 갑상선센터장
2014.04 ~현재 성균관대학교 의과대학 내과 교수
2008.02 ~현재 삼성서울병원 내분비대사내과 전문의
2017.04 ~ 2021.03 삼성서울병원 내분비-대사 내과 과장
2016.03 ~ 2017.03 삼성서울병원 SMC파트너즈센터 부센터장
2008.03 ~ 2014.03 성균관대학교 의과대학 내과 부교수
2012.03 ~ 2013.02 삼성서울병원 내분비-대사 내과 의국장
2009.03 ~ 2010.02 삼성서울병원 내분비-대사 내과 의국장
2002.09 ~ 2008.01 국립암센터 갑상선암클리닉 책임의 및 연구소 선임연구원
2000.09 ~ 2002.08 제주대학교 의과대학 전임강사
2001.08 내분비-대사 내과 분과전문의 자격 취득
2000.03 ~ 2000.08 제주의료원 내과과장
1999.03 ~ 2000.02 서울대학교병원 내분비대사내과 전임의
1997.03 내과 전문의 자격 취득
1993.03 ~ 1997.02 서울대학교병원 내과 전공의(레지던트)
1992.03 ~ 1993.02 서울대학교병원 전공의(인턴)

학회활동

학회활동
AOTA (아시아-오세아니아 갑상선학회)
The Endocrine Society
대한갑상선학회
대한내분비학회
대한당뇨병학회
미국갑상선학회(American Thyroid Association)
유럽갑상선학회
논문
  • J CLIN ENDOCR METAB 2023 10.1210/clinem/dgad684 Malignancy Risk of Follicular Neoplasm (Bethesda IV) With Variable Cutoffs of Tumor Size: A Systemic Review and Meta-Analysis Cho, YY; Ahn, SH; Lee, EK; Park, YJ; Choi, D; Kim, BY; Jung, CH; Mok, JO; Kim, CH; Kim, SW
    View PubMed
  • PLOS ONE 2023 10.1371/journal.pone.0294145 Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma Heo, J; Lee, S; Park, J; Yang, HR; Park, H; Ki, CS; Oh, YL; Kim, HI; Kim, SW; Chung, JH; Kim, K; Kim, TH
    View PubMed
  • ENDOCRINE 2023 10.1007/s12020-023-03510-8 Mortality rate and causes of death in papillary thyroid microcarcinoma Heo, J; Ryu, HJ; Park, H; Kim, TH; Kim, SW; Oh, YL; Chung, JH
    View PubMed
  • SCI REP-UK 2023 10.1038/s41598-023-42907-3 Preoperative identification of low-risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy Park, H; Ryu, HJ; Heo, J; Chung, MK; Son, YI; Kim, JH; Hahn, SY; Shin, JH; Oh, YL; Kim, SW; Chung, JH; Kim, JS; Kim, TH
    View PubMed
  • SCI REP-UK 2023 10.1038/s41598-023-29071-4 Association between urinary iodine concentration and the risk of papillary thyroid cancer by sex and age: a case-control study Hwang, Y; Oh, HK; Chung, JH; Kim, SW; Kim, JH; Kim, JS; Shin, MH
    View PubMed
  • THYROID 2023 10.1089/thy.2022.0216 Dyslipidemia Is a Risk Factor for Hypothyroidism in Women: A Longitudinal Cohort Study from South Korea Kim, HI; Kim, TH; Kim, H; Kim, SW; Hahm, JR; Chung, JH
    View PubMed
  • ANN SURG ONCOL 2023 10.1245/s10434-022-13089-5 Selection Criteria for Completion Thyroidectomy in Follicular Thyroid Carcinoma Using Primary Tumor Size and TERT Promoter Mutational Status Park, H; Heo, J; Ki, CS; Shin, JH; Oh, YL; Son, YI; Kim, JS; Kim, SW; Chung, JH; Kim, TY; Kim, TH; Kim, JH
    View PubMed
  • ANN SURG ONCOL 2023 10.1245/s10434-023-13146-7 ASO Visual Abstract: Selection Criteria for Completion Thyroidectomy in Follicular Thyroid Carcinoma Using Primary Tumor Size and TERT Promoter Mutational Status Park, H; Heo, J; Ki, CS; Shin, JH; Oh, YL; Son, YI; Kim, JS; Kim, SW; Chung, JH; Kim, TY; Kim, TH; Kim, JH
    View PubMed
  • ENDOCRINOL METAB 2022 10.3803/EnM.2022.1591 Identification of Mutations in the Thyroxine-Binding Globulin (TBG) Gene in Patients with TBG Deficiency in Korea Heo, J; Kim, SM; Ryu, HJ; Park, H; Kim, TH; Chung, JH; Park, HD; Kim, SW
    View PubMed
  • FRONT ENDOCRINOL 2022 10.3389/fendo.2022.1032764 Graves' disease, its treatments, and the risk of atrial fibrillation: A Korean population-based study Cho, YY; Kim, B; Choi, D; Kim, CH; Shin, DW; Kim, JS; Park, SJ; Kim, SW; Chung, JH; Han, K; Kim, TH
    View PubMed
  • ULTRASONOGRAPHY 2022 10.14366/usg.21264 Ultrasonographic characteristics of H?rthle cell neoplasms: prediction of malignancy Kim, MJ; Shin, JH; Hahn, SY; Oh, YL; Kim, SW; Kim, TH; Lim, Y; Lee, SHY
    View PubMed
  • EPILEPSIA 2022 10.1111/epi.17407 The longitudinal effect of oxcarbazepine on thyroid function in children and adolescents with epilepsy Park, H; Heo, J; Kim, MJ; Lee, JH; Kim, MS; Jin, DK; Kim, TH; Chung, JH; Cho, SY; Kim, SW
    View PubMed
  • ENDOCRINOL METAB 2022 10.3803/EnM.2022.1477 Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients Yang, HR; Park, H; Ryu, HJ; Heo, J; Kim, JS; Oh, YL; Choe, JH; Kim, JH; Kim, JS; Jang, HW; Kim, TH; Kim, SW; Chung, JH
    View PubMed
  • ENDOCRINOL METAB 2022 10.3803/EnM.2022.1429 Bone Mineral Density Screening Interval and Transition to Osteoporosis in Asian Women Park, H; Yang, H; Heo, J; Jang, HW; Chung, JH; Kim, TH; Min, YK; Kim, SW
    View PubMed
  • ENDOCRINOL METAB 2022 10.3803/EnM.2021.1333 Graves' Disease and the Risk of End-Stage Renal Disease: A Korean Population-Based Study Cho, YY; Kim, B; Shin, DW; Jang, HR; Kim, BY; Jung, CH; Kim, JH; Kim, SW; Chung, JH; Han, K; Kim, TH
    View PubMed
  • ENDOCR-RELAT CANCER 2022 10.1530/ERC-21-0403 Effect of TSH levels during active surveillance of PTMC according to age Kim, HI; Jin, M; Ko, NG; Oh, YL; Shin, JH; Kim, JH; Kim, JS; Jeon, MJ; Kim, TY; Kim, SW; Kim, WB; Chung, JH; Shong, YK; Kim, WG; Kim, TH
    View PubMed
  • CANCERS 2022 10.3390/cancers14061470 Is Maintaining Thyroid-Stimulating Hormone Effective in Patients Undergoing Thyroid Lobectomy for Low-Risk Differentiated Thyroid Cancer? A Systematic Review and Meta-Analysis Won, HR; Jeon, E; Chang, JW; Kang, YE; Song, K; Kim, SW; Lim, DM; Ha, TK; Chung, KW; Kim, HJ; Park, YJ; Koo, BS
    View PubMed
  • CLIN ENDOCRINOL 2022 10.1111/cen.14698 Bone-density testing interval and transition to osteoporosis in differentiated thyroid carcinoma patients on TSH suppression therapy Park, H; Park, J; Yoo, H; Kim, S; Koh, JH; Jee, JH; Min, YK; Chung, JH; Kim, TH; Kang, M; Kim, SW
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-01898-9 Pattern analysis for prognosis of differentiated thyroid cancer according to preoperative serum thyrotropin levels Kim, H; Jung, J; Cho, YS; Choi, JY; Park, H; You-Bin Lee; Kim, SW; Chung, JH; Kim, TH
    View PubMed
  • CANCERS 2021 10.3390/cancers13225842 Metastatic Lymph Node Ratio for Predicting Recurrence in Medullary Thyroid Cancer Kim, J; Park, J; Park, H; Choi, MS; Jang, HW; Kim, TH; Kim, SW; Chung, JH
    View PubMed
  • FRONT ENDOCRINOL 2021 10.3389/fendo.2021.749973 Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma Park, H; Park, SY; Park, J; Choe, JH; Chung, MK; Woo, SY; Choi, JY; Kim, SW; Chung, JH; Kim, TH
    View PubMed
  • MODERN PATHOL 2021 10.1038/s41379-021-00907-6 Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations Park, H; Shin, HC; Yang, H; Heo, J; Ki, CS; Kim, HS; Kim, JH; Hahn, SY; Chung, YJ; Kim, SW; Chung, JH; Oh, YL; Kim, TH
    View PubMed
  • CANCERS 2021 10.3390/cancers13184670 Long-Term Outcomes and Causes of Death among Medullary Thyroid Carcinoma Patients with Distant Metastases Park, H; Yang, H; Heo, J; Kim, TH; Kim, SW; Chung, JH
    View PubMed
  • ANN SURG ONCOL 2021 10.1245/s10434-021-10383-6 Surgeon Volume and Long-Term Oncologic Outcomes in Patients with Medullary Thyroid Carcinoma Park, H; Kim, HI; Choe, JH; Chung, MK; Son, YI; Hahn, SY; Hwang, NY; Woo, SY; Kim, SW; Chung, JH; Kim, TH; Kim, JS
    View PubMed
  • THYROID 2021 10.1089/thy.2020.0756 Changes in Thyrotropin Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves' Disease Kim, J; Choi, MS; Park, J; Park, H; Jang, HW; Choe, JH; Kim, JH; Kim, JS; Cho, YS; Choi, JY; Kim, TH; Chung, JH; Kim, SW
    View PubMed
  • ENDOCRINOL METAB 2021 10.3803/EnM.2020.943 A Multicenter, Randomized, Controlled Trial for Assessing the Usefulness of Suppressing Thyroid Stimulating Hormone Target Levels after Thyroid Lobectomy in Low Intermediate Risk Thyroid Cancer Patients (MASTER): A Study Protocol Lee1, EK; Kang, YE; Park, YJ; Koo, BS; Chung, KW; Ku, EJ; Won, HR; Yoo, WS; Jeon, E; Paek, SH; Lee, YS; Lim, DM; Suh, YJ; Park, H; Kim, HJ; Kim, BH; Kim, M; Kim, SW; Yi, KH; Park, SK; Jung, EJ; Choi, JY; Bae, JS; Hong, JH; Nam, KH; Lee, YK; Yu, HW; Go, S; Kang, YM
    View PubMed
  • CANCERS 2021 10.3390/cancers13122943 Proposal of a New Prognostic Model for Differentiated Thyroid Cancer with TERT Promoter Mutations Park1, J; Lee, S; Park, J; Park, H; Ki, CS; Oh, YL; Shin, JH; Kim, JS; Kim, SW; Chung, JH; Kim, K; Kim, TH
    View PubMed
  • FRONT ENDOCRINOL (LAUSANNE) 2021 10.3389/fendo.2021.681148 Trends in Childhood Thyroid Cancer incidence in Korea and Its Potential Risk Factors Park1, J; Park, H; Kim, TH; Kim, SW; Jang, HW; Chung, JH
    View PubMed
  • ENDOCRINE 2021 10.1007/s12020-021-02725-x The longer the antithyroid drug is used, the lower the relapse rate in Graves' disease: a retrospective multicenter cohort study in Korea Park1, SY; Kim, BH; Kim, M; Hong, AR; Park, J; Park, H; Choi, MS; Kim, TH; Kim, SW; Kang, HC; Chung, JH
    View PubMed
  • CANCERS 2021 10.3390/cancers13081913 Prognostic Value of the Neutrophil-to-Lymphocyte Ratio before and after Radiotherapy for Anaplastic Thyroid Carcinoma Park1, J; Park, J; Shin, JH; Oh, YL; Jung, HA; Chung, MK; Choe, JH; Ahn, YC; Kim, SW; Chung, JH; Kim, TH; Noh, JM
    View PubMed
  • CANCERS 2021 10.3390/cancers13081948 Comparison of Four Ultrasonography-Based Risk Stratification Systems in Thyroid Nodules with Nondiagnostic/Unsatisfactory Cytology: A Real-World Study Lee1, YB; Oh, YL; Shin, JH; Kim, SW; Chung, JH; Min, YK; Hahn, SY; Kim, TH
    View PubMed
  • ENDOCRINOL METAB 2021 10.3803/EnM.2020.890 Protocol for a Korean Multicenter Prospective Cohort Study of Active Surveillance or Surgery (KoMPASS) in Papillary Thyroid Microcarcinoma Jeon1, MJ; Kang, YE; Moon, JH; Lim, DJ; Lee, CY; Lee, YS; Kim, SW; Kim, MH; Kim, BH; Kang, HC; Shong, M; Cho, SW; Kim, WB
    View PubMed
  • CANCERS 2021 10.3390/cancers13040648 TERT Promoter Mutations and the 8th Edition TNM Classification in Predicting the Survival of Thyroid Cancer Patients Park1, J; Lee, S; Kim, K; Park, H; Ki, CS; Oh, YL; Shin, JH; Kim, JS; Kim, SW; Chung, JH; Kim, TH
    View PubMed
  • CANCERS 2020 10.3390/cancers12102894 Preoperative Serum Calcitonin and Its Correlation with Extent of Lymph Node Metastasis in Medullary Thyroid Carcinoma Park1, H; Park, J; Choi, MS; Kim, J; Kim, H; Shin, JH; Kim, JH; Kim, JS; Kim, SW; Chung, JH; Kim, TH
    View PubMed
  • CANCERS 2020 10.3390/cancers12082323 Clinical Course from Diagnosis to Death in Patients with Well-Differentiated Thyroid Cancer Park1, H; Park, J; Park, SY; Kim, TH; Kim, SW; Chung, JH
    View PubMed
  • INT J MOL SCI 2020 10.3390/ijms21165629 Highly Sensitive and Specific Molecular Test for Mutations in the Diagnosis of Thyroid Nodules A Prospective Study ofBRAF-Prevalent Population Cho1, YY; Park, SY; Shin, JH; Oh, YL; Choe, JH; Kim, JH; Kim, JS; Yim, HS; Kim, YL; Ki, CS; Kim, TH; Chung, JH; Kim, SW
    View PubMed
  • NUCL MED COMMUN 2020 10.1097/MNM.0000000000001138 The success rate of radioactive iodine therapy for Graves' disease in iodine-replete area and affecting factors: a single-center study Park1, H; Kim, HI; Park, J; Park, SY; Kim, TH; Chung, JH; Choi, JY; Kim, SW
    View PubMed
  • CANCERS 2020 10.3390/cancers12030625 Preoperative Serum Thyroglobulin and Its Correlation with the Burden and Extent of Differentiated Thyroid Cancer Kim1, H; Park, SY; Choe, JH; Kim, JS; Hahn, SY; Kim, SW; Chung, JH; Jung, J; Kim, TH
    View PubMed
  • CLIN ENDOCRINOL 2020 10.1111/cen.14167 Ultrasound-guided fine-needle aspiration or core needle biopsy for diagnosing follicular thyroid carcinoma? Park1, KW; Shin, JH; Hahn, SY; Oh, YL; Kim, SW; Kim, TH; Chung, JH
    View PubMed
  • SCI REP-UK 2019 10.1038/s41598-019-55370-w Improved survival after early detection of asymptomatic distant metastasis in patients with thyroid cancer Kim1, H; Park, SY; Jung, J; Kim, JH; Hahn, SY; Shin, JH; Oh, YL; Chung, MK; Kim, HI; Kim, SW; Chung, JH; Kim, TH
    View PubMed
  • THYROID 2019 10.1089/thy.2019.0022 Lesion-Based Evaluation Predicts Treatment Response to Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Korean Multicenter Retrospective Study Lee1, EK; Kim, SM; Kim, BH; Kim, MJ; Lim, DJ; Kim, MH; Shin, DY; Kang, HC; Ahn, BC; Kim, SW; Ahn, HY; Park, YJ
    View PubMed
  • THYROID 2019 10.1089/thy.2019.0261 Multifocality in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma Is an Important Clue for the Diagnosis of Familial Adenomatous Polyposis Park1, J; Kim, JW; Park, H; Park, SY; Kim, TH; Kim, SW; Oh, YL; Chung, JH
    View PubMed
  • EUR ARCH OTO-RHINO-L 2019 10.1007/s00405-019-05702-3 Randomized trial of prophylactic ipsilateral central lymph node dissection in patients with clinically node negative papillary thyroid microcarcinoma Kim1, BY; Choi, N; Kim, SW; Jeong, HS; Chung, MK; Son, YI
    View PubMed
  • EUR J NUTR 2019 10.1007/s00394-018-1837-4 Non-immune-related hypothyroidism and its relationship with excess iodine Kim1, HI; Oh, HK; Park, SY; Jang, HW; Shin, MH; Han, JM; Bae, JC; Kim, SW; Kim, TH; Chung, JH
    View PubMed
  • THYROID 2019 10.1089/thy.2019.0091 Increased Morbidity of Major Depressive Disorder After Thyroidectomy: A Nationwide Population-Based Study in South Korea Choi1, KW; Kim, Y; Fava, M; Mischoulon, D; Na, EJ; Kim, SW; Shin, MH; Chung, MK; Jeon, HJ
    View PubMed
  • HEAD NECK-J SCI SPEC 2019 10.1002/hed.25721 Prediction of follicular thyroid carcinoma associated with distant metastasis in the preoperative and postoperative model Kim1, H; Shin, JH; Hahn, SY; Oh, YL; Kim, SW; Park, KW; Lim, Y
    View PubMed
  • THYROID 2019 10.1089/thy.2018.0541 Impact of Extranodal Extension on Risk Stratification in Papillary Thyroid Carcinoma Kim1, HI; Hyeon, J; Park, SY; Ahn, HS; Kim, K; Han, JM; Bae, JC; Shin, JH; Kim, JS; Kim, SW; Chung, JH; Kim, TH; Oh, YL
    View PubMed
  • ENDOCRINE 2019 10.1007/s12020-018-1807-x Long-term outcomes of renal function after radioactive iodine therapy for thyroid cancer according to preparation method: thyroid hormone withdrawal vs. recombinant human thyrotropin Cho1, YY; Kim, SK; Jung, JH; Hahm, JR; Kim, TH; Chung, JH; Kim, SW
    View PubMed
  • EUR J NUTR 2019 10.1007/s00394-017-1587-8 Urinary iodine concentration and thyroid hormones: Korea National Health and Nutrition Examination Survey 2013-2015 Kim1, HI; Oh, HK; Park, SY; Jang, HW; Shin, MH; Kim, SW; Kim, TH; Chung, JH
    View PubMed
  • ORAL ONCOL 2019 10.1016/j.oraloncology.2018.12.014 Refining the tumor-node-metastasis staging system for individualized treatment of differentiated thyroid carcinoma Kim1, YN; Kim, M; Ahn, HS; Kim, K; Park, SY; Kim, HI; Jeon, MJ; Kim, WG; Kim, SW; Kim, WB; Chung, JH; Shong, YK; Kim, TY; Kim, TH
    View PubMed
  • ORAL ONCOL 2018 10.1016/j.oraloncology.2018.10.029 Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort study Kim1, M; Kim, HI; Jeon, MJ; Kim, HK; Kim, EH; Yi, HS; Kim, ES; Kim, H; Kim, BH; Kim, TY; Kim, SW; Kang, HC; Kim, WB; Chung, JH; Shong, YK; Kim, TH; Kim, WG
    View PubMed
  • J CLIN ENDOCR METAB 2018 10.1210/jc.2018-01386 Clinical Validation of the Prognostic Stage Groups of the Eighth-Edition TNM Staging for Medullary Thyroid Carcinoma Park1, SY; Cho, YY; Kim, HI; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Kim, K; Kim, SW; Chung, JH; Kim, TH
    View PubMed
  • THYROID 2018 10.1089/thy.2018.0263 Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma: A Multi-Center Cohort Study in Korea Oh1, HS; Ha, J; Kim, HI; Kim, TH; Kim, WG; Lim, DJ; Kim, TY; Kim, SW; Kim, WB; Shong, YK; Chung, JH; Baek, JH
    View PubMed
  • ORAL ONCOL 2018 10.1016/j.oraloncology.2018.09.008 Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study Kim1, M; Kim, HK; Kim, HI; Kim, EH; Jeon, MJ; Yi, HS; Kim, ES; Kim, H; Kim, TH; Kim, BH; Kim, TY; Kang, HC; Kim, WB; Chung, JH; Shon, YK; Kim, SW; Kim, WG
    View PubMed
  • SCI REP-UK 2018 10.1038/s41598-018-31955-9 Modified Bethesda system informing cytopathologic adequacy improves malignancy risk stratification in nodules considered benign or atypia(follicular lesion) of undetermined significance Lee1, YB; Kim, JY; Cho, H; Hahn, SY; Shin, JH; Lee, SE; Jun, JE; Kim, SW; Chung, JH; Kim, TH; Oh, YL
    View PubMed
  • ORAL ONCOL 2018 10.1016/j.oraloncology.2018.07.002 Low versus high activity radioiodine remnant ablation for differentiated thyroid carcinoma with gross extrathyroidal extension invading only strap muscles Park1, SY; Kim, HI; Choi, JY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Ahn, SH; Kim, K; Jeong, JG; Kim, SW; Chung, JH; Kim, TH
    View PubMed
  • BRIT J SURG 2018 10.1002/bjs.10830 Prognostic significance of gross extrathyroidal extension invading only strap muscles in differentiated thyroid carcinoma Park1, SY; Kim, HI; Kim, JH; Kim, JS; Oh, YL; Kim, SW; Chung, JH; Jang, HW; Kim, TH
    View PubMed
  • THYROID 2018 10.1089/thy.2017.0550 Protective Effect of Metformin Against Thyroid Cancer Development: A Population-Based Study in Korea Cho1, YY; Kang, MJ; Kim, SK; Jung, JH; Hahm, JR; Kim, TH; Nam, JY; Lee, BW; Lee, YH; Chung, JH; Song, SO; Kim, SW
    View PubMed
  • KOREAN JOURNAL OF INTERNAL MEDICINE 2018 10.3904/kjirn.2016.051 Reference intervals of thyroid hormones during pregnancy in Korea, an iodine-replete area Kim1, HJ; Cho, YY; Kim, SW; Kim, TH; Jang, HW; Lee, SY; Choi, SJ; Roh, CR; Kim, JH; Chung, JH; Oh, SY
    View PubMed
  • HISTOPATHOLOGY 2018 10.1111/his.13401 Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma Kim1, TH; Lee, M; Kwon, AY; Choe, JH; Kim, JH; Kim, JS; Hahn, SY; Shin, JH; Chung, MK; Son, YI; Ki, CS; Yim, HS; Kim, YL; Chung, JH; Kim, SW; Oh, YL
    View PubMed
  • EUR J NUTR 2018 10.1007/s00394-016-1370-2 Iodine intake as a risk factor for BRAF mutations in papillary thyroid cancer patients from an iodine-replete area Kim1, HJ; Park, HK; Byun, DW; Suh, K; Yoo, MH; Min, YK; Kim, SW; Chung, JH
    View PubMed
  • ORAL ONCOL 2018 10.1016/j.oraloncology.2018.01.021 Refining the eighth edition AJCC TNM classification and prognostic groups for papillary thyroid cancer with lateral nodal metastasis Kim1, HI; Kim, K; Park, SY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Ahn, HS; Kim, SW; Kim, TH; Chung, JH
    View PubMed
  • J CLIN ENDOCR METAB 2018 10.1210/jc.2017-01775 High Serum TSH Level Is Associated With Progression of Papillary Thyroid Microcarcinoma During Active Surveillance Kim1, HI; Jang, HW; Ahn, HS; Ahn, S; Park, SY; Oh, YL; Hahn, SY; Shin, JH; Kim, JH; Kim, JS; Chung, JH; Kim, TH; Kim, SW
    View PubMed
  • PLoS One 2018 10.1371/journal.pone.0190738 Age- and gender-specific reference intervals of TSH and free T4 in an iodine-replete area: Data from Korean National Health and Nutrition Examination Survey IV (2013-2015) Park1, SY; Kim, HI; Oh, HK; Kim, TH; Jang, HW; Chung, JH; Shin, MH; Kim, SW
    View PubMed
  • BRIT J SURG 2018 10.1002/bjs.10655 Surgeon volume and prognosis of patients with advanced papillary thyroid cancer and lateral nodal metastasis Kim1, HI; Kim, TH; Choe, JH; Kim, JH; Kim, JS; Kim, YN; Kim, H; Kim, SW; Chung, JH
    View PubMed
  • Oncoimmunology 2018 10.1080/2162402X.2017.1375642 Development of thyroid dysfunction is associated with clinical response to PD-1 blockade treatment in patients with advanced non-small cell lung cancer Kim1, HI; Kim, M; Lee, SH; Park, SY; Kim, YN; Kim, H; Jeon, MJ; Kim, TY; Kim, SW; Kim, WB; Kim, SW; Lee, DH; Park, K; Ahn, MJ; Chung, JH; Shong, YK; Kim, WG; Kim, TH
    View PubMed
  • THYROID 2018 10.1089/thy.2017.0214 Practical Initial Risk Stratification Based on Lymph Node Metastases in Pediatric and Adolescent Differentiated Thyroid Cancer Jeon1, MJ; Kim, YN; Sung, TY; Hong, SJ; Cho, YY; Kim, TY; Shong, YK; Kim, WB; Kim, SW; Chung, JH; Kim, TH; Kim, WG
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.22430 Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations Hahn1, SY; Kim, TH; Ki, CS; Kim, SW; Ahn, S; Shin, JH; Chung, JH
    View PubMed
  • SCI REP-UK 2017 10.1038/s41598-017-17176-6 Preoperative serum thyroglobulin predicts initial distant metastasis in patients with differentiated thyroid cancer Kim1, H; Kim, YN; Kim, HI; Park, SY; Choe, JH; Kim, JH; Kim, JS; Chung, JH; Kim, TH; Kim, SW
    View PubMed
  • Cancer Med 2017 10.1002/cam4.1160 Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size Kim1, HI; Kim, TH; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Jang, HW; Kim, YN; Kim, H; Ahn, HS; Kim, K; Kim, SW; Chung, JH
    View PubMed
  • ENDOCRINE 2017 10.1007/s12020-017-1381-7 Validation of dynamic risk stratification in pediatric differentiated thyroid cancer Sohn1, SY; Kim, YN; Kim, HI; Kim, TH; Kim, SW; Chung, JH
    View PubMed
  • ENDOCRINE 2017 10.1007/s12020-017-1363-9 Hormetic effect of triiodothyronine in metabolically healthy obese persons Jun1, JE; Kim, TH; Lee, SE; Lee, YB; Jee, JH; Bae, JC; Jin, SM; Hur, KY; Kim, JH; Kim, SW; Chung, JH; Min, YK; Lee, MK
    View PubMed
  • CLIN ENDOCRINOL 2017 10.1111/cen.13344 Delayed TSH recovery after dose adjustment during TSH-suppressive levothyroxine therapy of thyroid cancer Kim1, HI; Kim, TH; Kim, H; Kim, YN; Jang, HW; Kim, JH; Hur, KY; Chung, JH; Kim, SW
    View PubMed
  • ORAL ONCOL 2017 10.1016/j.oraloncology.2017.06.004 Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma Kim1, TH; Kim, YN; Kim, HI; Park, SY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Kim, K; Jeong, JG; Kim, SW; Chung, JH
    View PubMed
  • ENDOCRINE 2017 10.1007/s12020-017-1340-3 Ultrasonographic prediction of highly aggressive telomerase reverse transcriptase (TERT) promoter-mutated papillary thyroid cancer Kim1, TH; Ki, CS; Hahn, SY; Oh, YL; Jang, HW; Kim, SW; Chung, JH; Shin, JH
    View PubMed
  • PLoS One 2017 10.1371/journal.pone.0182090 Subclinical thyroid dysfunction and risk of carotid atherosclerosis Kim1, H; Kim, TH; Kim, HI; Park, SY; Kim, YN; Kim, S; Kim, MJ; Jin, SM; Hur, KY; Kim, JH; Lee, MK; Min, YK; Chung, JH; Kang, M; Kim, SW
    View PubMed
  • THYROID 2017 10.1089/thy.2016.0648 Patterns of Initial Recurrence in Completely Resected Papillary Thyroid Carcinoma Kim1, H; Kim, TH; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Chi, SA; Jung, SH; Kim, YN; Kim, HI; Kim, SW; Chung, JH
    View PubMed
  • Eur J Endocrinol. 2017 Apr;176(4):441-450. doi: 10.1530/EJE-16-0734. Epub 2017 Jan 18. Association of triiodothyronine levels with future development of metabolic syndrome in euthyroid middle-aged subjects: a 6-year retrospective longitudinal study Kim HJ11, Bae JC2, Park HK1, Byun DW1, Suh K1, Yoo MH1, Jae Hwan J3, Kim JH4, Min YK4, Kim SW4, Chung JH5.
    View PubMed
  • Eur J Nutr. 2017 Apr;56(3):965-971. doi: 10.1007/s00394-015-1144-2. Epub 2016 Jan 8. Strong association of relatively low and extremely excessive iodine intakes with thyroid cancer in an iodine-replete area Kim HJ11, Kim NK2, Park HK1, Byun DW1, Suh K1, Yoo MH1, Min YK2, Kim SW2, Chung JH3.
    View PubMed
  • Endocrine. 2017 Mar;55(3):944-953. doi: 10.1007/s12020-016-1221-1. Epub 2017 Jan 2. TSH increment and the risk of incident type 2 diabetes mellitus in euthyroid subjects Jun JE11, Jin SM1, Jee JH2, Bae JC3, Hur KY1, Lee MK1, Kim SW1, Kim JH4,5.
    View PubMed
  • Clin Endocrinol (Oxf). 2017 Mar;86(3):438-443. doi: 10.1111/cen.13254. Epub 2016 Nov 2. Optimal cut-off age in the TNM Staging system of differentiated thyroid cancer: is 55 years better than 45 years? Kim M11, Kim YN2, Kim WG1, Park S1, Kwon H1, Jeon MJ1, Ahn HS3, Jung SH4, Kim SW2, Kim WB1, Chung JH2, Shong YK1, Kim TH2, Kim TY1.
    View PubMed
  • Endocr Relat Cancer. 2017 Feb;24(2):97-106. doi: 10.1530/ERC-16-0421. Comprehensive screening for PD-L1 expression in thyroid cancer Ahn S11, Kim TH2, Kim SW2, Ki CS3, Jang HW4, Kim JS5, Kim JH5, Choe JH5, Shin JH6, Hahn SY6, Oh YL7, Chung JH8.
    View PubMed
  • Endocrine. 2017 Feb;55(2):503-512. doi: 10.1007/s12020-016-1138-8. Epub 2016 Oct 5. The effect of TSH change per year on the risk of incident chronic kidney disease in euthyroid subjects Lee DY11,2, Jee JH3, Jun JE1, Kim TH1, Jin SM1, Hur KY1, Kim SW1, Chung JH1, Lee MK1, Kim JH4,5.
    View PubMed
  • Head Neck. 2017 Feb;39(2):269-274. doi: 10.1002/hed.24578. Epub 2016 Sep 12. Current status and diagnostic values of the Bethesda system for reporting thyroid cytopathology in a papillary thyroid carcinoma-prevalent area Lee YB11, Cho YY2, Jang JY3, Kim TH1, Jang HW4, Chung JH1, Oh YL5, Kim SW1.
    View PubMed
  • J Clin Endocrinol Metab. 2017 Feb 1;102(2):625-633. doi: 10.1210/jc.2016-2287. Long-Term Recurrence of Small Papillary Thyroid Cancer and Its Risk Factors in a Korean Multicenter Study Hwangbo Y11,2, Kim JM3, Park YJ2, Lee EK1, Lee YJ1, Park DJ2, Choi YS4, Lee KD5, Sohn SY6, Kim SW6, Chung JH6, Lim DJ7, Kim MH7, Kim MJ3, Jo YS8, Shong MH8, Koong SS9, Hahm JR10, Jung JH10, Yi KH2,11.
    View PubMed
  • Ann Lab Med. 2017 Jan;37(1):63-65. doi: 10.3343/alm.2017.37.1.63. First Report of Familial Dysalbuminemic Hyperthyroxinemia With an ALB Variant Cho YY11,2, Song JS3, Park HD3, Kim YN1, Kim HI1, Kim TH1, Chung JH1, Ki CS4, Kim SW5.
    View PubMed
  • PLoS One. 2017 Jan 12;12(1):e0169775. doi: 10.1371/journal.pone.0169775. eCollection 2017. Effect of Rifampin on Thyroid Function Test in Patients on Levothyroxine Medication Kim HI11, Kim TH1, Kim H1, Kim YN1, Jang HW2, Chung JH1, Moon SM3, Jhun BW3, Lee H3, Koh WJ3, Kim SW1.
    View PubMed
  • Thyroid. 2017 Jan;27(1):29-38. doi: 10.1089/thy.2016.0171. Epub 2016 Dec 9. Association Between Changes in Thyroid Hormones and Incident Type 2 Diabetes: A Seven-Year Longitudinal Study Jun JE11, Jee JH2, Bae JC3, Jin SM1, Hur KY1, Lee MK1, Kim TH1, Kim SW1, Kim JH1.
    View PubMed
  • Nutrients. 2016 Dec 8;8(12). pii: E797. A Prospective Study on Serum Methylmalonic Acid and Homocysteine in Pregnant Women Choi R11, Choi S2, Lim Y3, Cho YY4, Kim HJ5, Kim SW6, Chung JH7, Oh SY8, Lee SY9.
    View PubMed
  • Nutrients. 2016 Nov 23;8(11). pii: E749. A Prospective Study of Serum Trace Elements in Healthy Korean Pregnant Women Choi R11, Sun J2, Yoo H3, Kim S4, Cho YY5, Kim HJ6, Kim SW7, Chung JH8, Oh SY9, Lee SY10,11.
    View PubMed
  • Endocr Relat Cancer. 2016 Oct;23(10):813-23. doi: 10.1530/ERC-16-0219. Epub 2016 Aug 15. TERT promoter mutations and long-term survival in patients with thyroid cancer Kim TH11, Kim YE2, Ahn S3, Kim JY4, Ki CS5, Oh YL3, Kim K6, Yun JW7, Park WY7, Choe JH8, Kim JH8, Kim JS8, Kim SW1, Chung JH9.
    View PubMed
  • Head Neck. 2016 Oct;38(10):1501-8. doi: 10.1002/hed.24469. Epub 2016 Apr 7. Clinical outcomes of patients with hypercalcitoninemia after initial treatment for medullary thyroid cancer and postoperative serum calcitonin cutoffs for predicting structural recurrence Cho YY11, Jang HW2, Jang JY1, Kim TH1, Choe JH3, Kim JH3, Kim JS3, Kim SW1, Chung JH4.
    View PubMed
  • Ann Lab Med. 2016 Sep;36(5):413-9. doi: 10.3343/alm.2016.36.5.413. Performance Evaluation of the Serum Thyroglobulin Assays With Immunochemiluminometric Assay and Immunoradiometric Assay for Differentiated Thyroid Cancer Cho YY11, Chun S2, Lee SY2, Chung JH1, Park HD3, Kim SW4.
    View PubMed
  • Am J Clin Oncol. 2016 Aug;39(4):374-8. doi: 10.1097/COC.0000000000000072. Efficacy of Low-dose and High-dose Radioactive Iodine Ablation With rhTSH in Korean Patients With Differentiated Thyroid Carcinoma The First Report in Nonwestern Countries Joung JY11, Choi JH, Cho YY, Kim NK, Sohn SY, Kim SW, Chung JH.
    View PubMed
  • Histopathology. 2016 Jul;69(1):45-53. doi: 10.1111/his.12902. Epub 2016 Jan 11. Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications Joung JY11, Kim TH1, Jeong DJ1, Park SM1, Cho YY1, Jang HW2, Jung YY3, Oh YL3, Yim HS4, Kim YL4, Chung JH1, Ki CS5, Kim SW1.
    View PubMed
  • Thyroid. 2016 May;26(5):672-82. doi: 10.1089/thy.2015.0527. Highly Concordant Key Genetic Alterations in Primary Tumors and Matched Distant Metastases in Differentiated Thyroid Cancer Sohn SY11, Park WY2,3, Shin HT2, Bae JS2, Ki CS4, Oh YL5, Kim SW6, Chung JH6.
    View PubMed
  • Cancer Med. 2016 May;5(5):769-77. doi: 10.1002/cam4.636. Epub 2016 Jan 18. Triage of patients with AUS/FLUS on thyroid cytopathology: effectiveness of the multimodal diagnostic techniques Kim TH11, Jeong DJ1, Hahn SY2, Shin JH2, Oh YL3, Ki CS4, Kim JW4, Jang JY1, Cho YY1, Chung JH1, Kim SW1.
    View PubMed
  • Eur J Nutr. 2016 Mar;55(2):469-75. doi: 10.1007/s00394-015-0864-7. Epub 2015 Mar 7. Iodine status in healthy pregnant women in Korea: a first report Cho YY11, Kim HJ1,2, Oh SY3, Choi SJ3, Lee SY4, Joung JY1, Jeong DJ1, Sohn SY1, Chung JH1, Roh CR5, Kim SW6.
    View PubMed
  • PLoS One. 2015 Dec 17;10(12):e0145292. doi: 10.1371/journal.pone.0145292. eCollection 2015. A Modest Protective Effect of Thyrotropin against Bone Loss Is Associated with Plasma Triiodothyronine Levels Kim TH11, Joung JY1, Kang M2, Choi SK3, Kim K3, Jang JY1, Cho YY1, Min YK1, Chung JH1, Kim SW1.
    View PubMed
  • Thyroid. 2015 Aug;25(8):927-34. doi: 10.1089/thy.2014.0557. Epub 2015 Jul 2. Increased Risk of Leukemia After Radioactive Iodine Therapy in Patients with Thyroid Cancer: A Nationwide, Population-Based Study in Korea Seo GH11, Cho YY2, Chung JH2, Kim SW2.
    View PubMed
  • Ann Lab Med. 2015 May;35(3):387-9. doi: 10.3343/alm.2015.35.3.387. Epub 2015 Apr 1. Identification of p.Glu131Lys Mutation in the IHH Gene in a Korean Patient With Brachydactyly Type A1 Jang MA11, Kim OH2, Kim SW3, Ki CS1.
    View PubMed
  • Head Neck. 2015 May;37(5):650-4. doi: 10.1002/hed.23650. Epub 2014 Apr 10. Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma Kim HJ11, Park HK, Byun DW, Suh K, Yoo MH, Min YK, Kim SW, Chung JH.
    View PubMed
  • Nutrients. 2015 May 11;7(5):3427-48. doi: 10.3390/nu7053427. High Prevalence of Vitamin D Deficiency in Pregnant Korean Women: The First Trimester and the Winter Season as Risk Factors for Vitamin D Deficiency Choi R11, Kim S2, Yoo H3, Cho YY4, Kim SW5, Chung JH6, Oh SY7, Lee SY8.
    View PubMed
  • Endocr J. 2015;62(3):243-50. doi: 10.1507/endocrj.EJ14-0384. Epub 2014 Dec 4. Diagnostic accuracy of plasma free metanephrines in a seated position compared with 24-hour urinary metanephrines in the investigation of pheochromocytoma Kim HJ11, Lee JI, Cho YY, Lee SY, Kim JH, Jung BC, Kim SW, Chung JH, Min YK, Lee MS, Lee MK, Kim JH.
    View PubMed
  • Eur J Clin Nutr. 2015 Mar;69(3):361-6. doi: 10.1038/ejcn.2014.284. Epub 2015 Feb 4. Effect of high dietary sodium on bone turnover markers and urinary calcium excretion in Korean postmenopausal women with low bone mass Park SM11, Joung JY1, Cho YY1, Sohn SY1, Hur KY1, Kim JH1, Kim SW1, Chung JH1, Lee MK1, Min YK1.
    View PubMed
  • Cancer. 2015 Jan 15;121(2):259-68. doi: 10.1002/cncr.29025. Epub 2014 Sep 15. Elevated Risks of Subsequent Primary Malignancies in Patients With Thyroid Cancer: A Nationwide, Population-Based Study in Korea Cho YY11, Lim J, Oh CM, Ryu J, Jung KW, Chung JH, Won YJ, Kim SW.
    View PubMed
  • Head Neck. 2014 Dec;36(12):1695-700. doi: 10.1002/hed.23511. Epub 2014 Feb 27. Association of vascular invasion with increased mortality in patients with minimally invasive follicular thyroid carcinoma but not widely invasive follicular thyroid carcinoma Kim HJ11, Sung JY, Oh YL, Kim JH, Son YI, Min YK, Kim SW, Chung JH.
    View PubMed
  • Thyroid. 2014 Sep;24(9):1361-8. doi: 10.1089/thy.2014.0046. Epub 2014 Jun 30. Effect of Iodine Restriction on Thyroid Function in Subclinical Hypothyroid Patients in an Iodine-Replete Area: A Long Period Observation in a Large-Scale Cohort Joung JY11, Cho YY, Park SM, Kim TH, Kim NK, Sohn SY, Kim SW, Chung JH.
    View PubMed
  • Clin Chem Lab Med. 2014 Jul;52(7):e139-42. doi: 10.1515/cclm-2013-1007. Evaluation of mutation profiling by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry in fine needle aspirations from papillary thyroid cancer Woo HI1, Kim SW, Ki CS, Shin JH, Oh YL, Kim JW, Chung JH.
    View PubMed
  • Asian Pac J Cancer Prev. 2014;15(12):5107-10. Effectiveness of Ultrasonographic Screening for Thyroid Cancer: Round-table Conference in the National Evidence-based Healthcare Collaborating Agency (NECA) in conjunction with the Korean Thyroid Association Shin S11, Park SE, Kim SY, Hyun MK, Kim SW, Kwon JW, Kim Y, Kim WB, Na DG, Park HA, Sheen SS, Yi KH, Chang HS, Cho JJ, Chung JH.
    View PubMed
  • Thyroid. 2014 May;24(5):872-7. doi: 10.1089/thy.2013.0238. Epub 2014 Mar 6. The Impact of Iodinated Contrast Agent Administered During Preoperative Computed Tomography Scan on Body Iodine Pool in Patients with Differentiated Thyroid Cancer Preparing for Radioactive Iodine Treatment Sohn SY11, Choi JH, Kim NK, Joung JY, Cho YY, Park SM, Kim TH, Jin SM, Bae JC, Lee SY, Chung JH, Kim SW.
    View PubMed
  • Endocrine. 2014 Mar;45(2):256-62. doi: 10.1007/s12020-013-9997-8. Epub 2013 Jul 3. Role of autophagy in the resistance to tumour necrosis factor-related apoptosis-inducing ligand-induced apoptosis in papillary and anaplastic thyroid cancer cells Jin SM11, Jang HW, Sohn SY, Kim NK, Joung JY, Cho YY, Kim SW, Chung JH.
    View PubMed
  • J Diabetes Investig. 2014 Feb 12;5(1):51-9. doi: 10.1111/jdi.12127. Epub 2013 Sep 2. Predictive factors of durability to sitagliptin: Slower reduction of glycated hemoglobin, older age and higher baseline glycated hemoglobin Chung HS11, Suh S2, Kim MY3, Kim SK3, Kim HK3, Lee JI3, Hur KY3, Kim JH3, Min YK3, Lee MS3, Kim KW3, Kim SW3, Chung JH3, Lee MK3.
    View PubMed
  • Head Neck. 2014 Jan;36(1):43-6. doi: 10.1002/hed.23252. Epub 2013 Jun 1. Lack of association between high serum thyroid-stimulating hormone level and risk of papillary thyroid microcarcinomas Sohn SY11, Kim HJ, Jang HW, Kim SW, Chung JH.
    View PubMed
  • Korean J Intern Med. 2013 Nov;28(6):724-7. doi: 10.3904/kjim.2013.28.6.724. Epub 2013 Oct 29. Postinfectious Guillain-Barre syndrome in a patient with methimazole-induced agranulocytosis Cho YY11, Joung JY, Jeong H, Je D, Hong YS, Suh S, Kim SW.
    View PubMed
  • Clin Endocrinol (Oxf). 2013 Sep;79(3):445. doi: 10.1111/cen.12131. Epub 2013 Apr 5. Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma Kim HJ1, Kim SW.
    View PubMed
  • Thyroid. 2013 Jun;23(6):741-7. doi: 10.1089/thy.2012.0136. Association Between Excessive Urinary Iodine Excretion and Failure of Radioactive Iodine Thyroid Ablation in Patients with Papillary Thyroid Cancer Sohn SY11, Choi JY, Jang HW, Kim HJ, Jin SM, Kim SW, Suh S, Hur KY, Kim JH, Chung JH, Kim SW.
    View PubMed
  • Clin Endocrinol (Oxf). 2013 Apr;78(4):614-20. doi: 10.1111/cen.12034. Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma Kim HJ11, Kim NK, Choi JH, Kim SW, Jin SM, Suh S, Bae JC, Min YK, Chung JH, Kim SW.
    View PubMed
  • Endocr Res. 2013;38(2):89-97. doi: 10.3109/07435800.2012.723292. ERK Phosphorylation Is Not Increased in Papillary Thyroid Carcinomas with BRAF(V600E) Mutation Compared to That of Corresponding Normal Thyroid Tissues Kim SW11, Kim HK, Lee JI, Jang HW, Choe JH, Kim JH, Kim JS, Hur KY, Kim JH, Chung JH.
    View PubMed
  • Head Neck. 2013 Jan;35(1):E13-7. doi: 10.1002/hed.21784. Epub 2011 Nov 22. Postoperative spindle cell nodule after thyroidectomy: A case mimicking recurrence with anaplastic transformation of thyroid cancer Kim SW11, Oh YL, Choi JY, Lee JI, Chung JH, Kim JS.
    View PubMed
  • Clin Endocrinol (Oxf). 2013 Jan;78(1):134-40. doi: 10.1111/j.1365-2265.2012.04506.x. Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer Kim HJ11, Kim NK, Choi JH, Sohn SY, Kim SW, Jin SM, Jang HW, Suh S, Min YK, Chung JH, Kim SW.
    View PubMed
  • Clin Endocrinol (Oxf). 2012 Sep;77(3):459-64. doi: 10.1111/j.1365-2265.2012.04396.x. Time trend in tumour size and characteristics of anaplastic thyroid carcinoma Han JM11, Bae Kim W, Kim TY, Ryu JS, Gong G, Hong SJ, Kim JH, Oh YL, Jang HW, Kim SW, Chung JH, Shong YK.
    View PubMed
  • J Clin Endocrinol Metab. 2012 Jul;97(7):2299-306. doi: 10.1210/jc.2011-3135. Epub 2012 Apr 12. Clinical Implication of Highly Sensitive Detection of the BRAF V600E Mutation in Fine-Needle Aspirations of Thyroid Nodules: A Comparative Analysis of Three Molecular Assays in 4585 Consecutive Cases in a BRAF V600E Mutation-Prevalent Area Lee ST11, Kim SW, Ki CS, Jang JH, Shin JH, Oh YL, Kim JW, Chung JH.
    View PubMed
  • J Korean Surg Soc. 2012 May;82(5):271-80. doi: 10.4174/jkss.2012.82.5.271. Epub 2012 Apr 26. Gene expression profiling of papillary thyroid carcinomas in Korean patients by oligonucleotide microarrays Chung KW11, Kim SW, Kim SW.
    View PubMed
  • Head Neck. 2012 May;34(5):696-701. doi: 10.1002/hed.21808. Epub 2011 Jul 11. Identification of a cut-off for the macis score to predict the prognosis of differentiated thyroid carcinoma in children and young adults Jang HW11, Lee JI, Kim HK, Oh YL, Choi YL, Jin DK, Kim JH, Chung JH, Kim SW.
    View PubMed
  • Head Neck. 2012 Feb;34(2):201-6. doi: 10.1002/hed.21716. Epub 2011 Jun 29. Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma Kim HK11, Oh YL, Kim SH, Lee DY, Kang HC, Lee JI, Jang HW, Hur KY, Kim JH, Min YK, Chung JH, Kim SW.
    View PubMed
  • Clin Endocrinol (Oxf). 2011 Dec;75(6):851-6. doi: 10.1111/j.1365-2265.2011.04157.x. Daily urine iodine excretion while consuming a low-iodine diet in preparation for radioactive iodine therapy in a high iodine intake area Kim HK11, Lee SY, Lee JI, Jang HW, Kim SK, Chung HS, Tan AH, Hur KY, Kim JH, Chung JH, Kim SW.
    View PubMed
  • J Korean Med Sci. 2010 Sep;25(9):1368-71. doi: 10.3346/jkms.2010.25.9.1368. Epub 2010 Aug 12. A Case of Resistance to Thyroid Hormone with Thyroid Cancer Kim HK11, Kim D, Yoo EH, Lee JI, Jang HW, Tan AH, Hur KY, Kim JH, Kim KW, Chung JH, Kim SW.
    View PubMed
  • Head Neck. 2010 Sep;32(9):1161-6. doi: 10.1002/hed.21308. DIFFERENCES IN SERUM THYROGLOBULIN MEASUREMENTS BY 3 COMMERCIAL IMMUNORADIOMETRIC ASSAY KITS AND LABORATORY STANDARDIZATION USING CERTIFIED REFERENCE MATERIAL 457 (CRM-457) Lee JI11, Kim JY, Choi JY, Kim HK, Jang HW, Hur KY, Kim JH, Kim KW, Chung JH, Kim SW.
    View PubMed
  • Health Qual Life Outcomes. 2010 Sep 15;8:101. doi: 10.1186/1477-7525-8-101. Decreased health-related quality of life in disease-free survivors of differentiated thyroid cancer in Korea Lee JI11, Kim SH, Tan AH, Kim HK, Jang HW, Hur KY, Kim JH, Kim KW, Chung JH, Kim SW.
    View PubMed
  • J Clin Endocrinol Metab. 2010 Aug;95(8):3693-700. doi: 10.1210/jc.2009-2795. Epub 2010 May 25. BRAF(V600E) Mutation Analysis in Fine-Needle Aspiration Cytology Specimens for Evaluation of Thyroid Nodule: A Large Series in a BRAF(V600E)-Prevalent Population Kim SW11, Lee JI, Kim JW, Ki CS, Oh YL, Choi YL, Shin JH, Kim HK, Jang HW, Chung JH.
    View PubMed
  • J Histochem Cytochem. 2010 Aug;58(8):731-40. doi: 10.1369/jhc.2010.955906. Epub 2010 Apr 26. Pathologic Changes and Glucose Homeostasis According to Expression of Human Islet Amyloid Polypeptide in Type 2 Diabetic Patients Park JY11, No HS, Ahn YR, Oh SH, Kim YS, Kim SY, Jang KT, Kim SW, Chung JH, Min YK, Heo JS, Choi SH, Choi DW, Lee MS, Lee MK, Kim JH, Kim KW.
    View PubMed
  • Clin Endocrinol (Oxf). 2010 Jul;73(1):114-8. doi: 10.1111/j.1365-2265.2009.03774.x. Epub 2009 Dec 29. Usefulness of iodine/creatinine ratio from spot-urine samples to evaluate the effectiveness of low-iodine diet preparation for radioiodine therapy Kim HK11, Lee SY, Lee JI, Jang HW, Kim SK, Chung HS, Tan AH, Hur KY, Kim JH, Chung JH, Kim SW.
    View PubMed
  • Head Neck. 2010 Jan;32(1):68-75. doi: 10.1002/hed.21145. SPURIOUS HYPERCALCITONINEMIA IN PATIENTS WITH NODULAR THYROID DISEASE INDUCED BY HETEROPHILIC ANTIBODIES Kim JM11, Chung KW, Kim SW, Choi SH, Min HS, Kim JN, Won WJ, Kim SK, Lee JI, Chung JH, Kim SW.
    View PubMed
  • 없음 Somatic Mutational Analysis of MEN1 and Phenotypic Correlation in Sporadic Parathyroid Tumors